OptiNose, Inc.

NASDAQ:OPTN

9.6 (USD) • At close May 21, 2025
Bedrijfsnaam OptiNose, Inc.
Symbool OPTN
Munteenheid USD
Prijs 9.6
Beurswaarde 97,223,040
Dividendpercentage 0%
52-weken bereik 4.815 - 20.025
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Ramy A. Mahmoud M.D., M.P.H.
Website https://www.optinose.com

An error occurred while fetching data.

Over OptiNose, Inc.

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment

Vergelijkbare Aandelen

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

4 USD

Longeveron Inc. logo

Longeveron Inc.

LGVN

1.3 USD

Biomea Fusion, Inc. logo

Biomea Fusion, Inc.

BMEA

1.8 USD

Omeros Corporation logo

Omeros Corporation

OMER

3 USD

Chimerix, Inc. logo

Chimerix, Inc.

CMRX

8.54 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

0.444 USD

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

0.28 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)